Ignite Creation Date:
2024-05-06 @ 3:17 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04583072
Status:
COMPLETED
Last Update Posted:
2023-09-13
First Post:
2020-09-28
Brief Title:
Stockholm3 Validation Study in a Multi-Ethnic Cohort
Sponsor:
Organization:
Karolinska Institutet
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Venipuncture Prior to the biopsy the blood will be collected in 2 EDTA lavender top x 4 milliliters 8 milliliters total tubes will be removed after obtaining consent from the subjects One tube will be immediately centrifuged 10 minutes at 2000G and plasma decanted to a tube without additives this typically produces approximately 15 milliliters of plasma The decanted tube with plasma and the remaining EDTA tube with whole blood is then frozen and stored at -20 degrees Celsius until being shipped to the A3P lab for Stockholm3 testing and analysis at -20 degrees Celsius unless processing for DNA extraction and plasma analysis
Other biobanked specimens as described in the Study detailed description will be collected prospectively and will include plasma and Buffy Coat used for DNA extraction utilising the study inclusion and exclusion criteria
Enrollment Count:
2152
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 69046 |
Who Masked List: